Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | TGM2 | P21980 | 14/20 | 0.50 |
| ▸ | F13A1 | P00488 | 2/20 | 0.50 |
| ▸ | TGM1 | P22735 | 2/20 | 0.50 |
| ▸ | TGM6 | O95932 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.46 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.46 |
| ▸ | KLK7 | P49862 | 1/20 | 0.45 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28447032 | 0.91 | ITGB3 (0.62) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL13702142 | 0.85 | TLR2 (0.53) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL21009949 | 0.85 | ITGB3 (0.52) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL29930528 | 0.85 | ITGB3 (0.52) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL19708135 | 0.85 | ITGB3 (0.52) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL22694079 | 0.85 | ITGB3 (0.51) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL20975607 | 0.84 | ITGB3 (0.52) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL28399421 | 0.83 | DPP7 (0.57) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL22582335 | 0.83 | ITGB3 (0.49) | ITGB3ITGA2BTGM2F13A1TGM1 | |
| SCHEMBL14064950 | 0.82 | KLK7 (0.54) | ITGB3ITGA2BTLR2TLR1KLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111065390-B | Use of a KOR agonist in combination with a MOR agonist for the preparation of a medicament for the treatment of pain | 江苏恒瑞医药股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-114940700-A | Phenyl propionamide derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-108290926-B | Phenyl propionamide derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-111065631-B | Salt of phenylpropionamide derivative and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2021-10-08 | — | — | CN | disclosed |
| CN-109879934-B | Salt of phenylpropionamide derivative and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-111065390-A | Use of a KOR agonist in combination with a MOR agonist for the preparation of a medicament for the treatment of pain | 江苏恒瑞医药股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| CN-111065631-A | Salt of phenylpropionamide derivative and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2020-04-24 | — | — | CN | disclosed |